Evaluating Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Transitioning From Buprenorphine Maintenance Prior to First Dose of VIVITROL

NCT02696434 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

101

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Use Disorder

Interventions

DRUG: Naltrexone
DRUG: Placebo
DRUG: Buprenorphine

Sponsor

Alkermes, Inc.